Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

NCT00677716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: 131I-chTNT-1/B MAb (Cotara)

Sponsor

Peregrine Pharmaceuticals